Rankings
▼
Calendar
ALDX FY 2015 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALDX
Aldeyra Therapeutics, Inc.
$290M
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$18,778
Operating Income
-$12M
Net Income
-$12M
EPS (Diluted)
$-1.40
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$28M
Total Liabilities
$3M
Stockholders' Equity
$25M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$18,778
$0
—
Operating Income
-$12M
-$7M
-64.9%
Net Income
-$12M
-$5M
-133.1%
← FY 2014
All Quarters
Q1 2016 →